Skip to content

Drug interactions

Safinamide + Sofosbuvir-velpatasvir-voxilaprevir

Severity: Minor

Safinamide and Sofosbuvir-velpatasvir-voxilaprevir: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Safinamide may inhibit intestinal BCRP, which could increase absorption of BCRP substrates including sofosbuvir and voxilaprevir. The expected increase is modest and clinical significance is uncertain.

What this interaction means in plain words

Safinamide and Sofosbuvir-velpatasvir-voxilaprevir have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Safinamide belongs to Central Nervous System; Sofosbuvir-velpatasvir-voxilaprevir belongs to Anti Virals.

Evidence level: Low

Why it happens

Safinamide and its main metabolite may inhibit intestinal BCRP, increasing absorption of BCRP substrates.

What to do

No dose adjustment is expected; monitor for antiviral adverse effects and for increased safinamide effects.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Safinamide and Sofosbuvir-velpatasvir-voxilaprevir, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Safinamide with Sofosbuvir-velpatasvir-voxilaprevir?

MediHelp rates the interaction as minor. Safinamide and Sofosbuvir-velpatasvir-voxilaprevir have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Safinamide may inhibit intestinal BCRP, which could increase absorption of BCRP substrates including sofosbuvir and voxilaprevir. The expected increase is modest and clinical significance is uncertain.

How serious is the interaction between Safinamide and Sofosbuvir-velpatasvir-voxilaprevir?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose adjustment is expected; monitor for antiviral adverse effects and for increased safinamide effects.

What other medicines interact with Sofosbuvir-velpatasvir-voxilaprevir?

MediHelp also lists interactions of Sofosbuvir-velpatasvir-voxilaprevir with, for example, Fosphenytoin, Phenobarbital, Phenytoin. The full list is on the Sofosbuvir-velpatasvir-voxilaprevir page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in